Literature DB >> 16828081

Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1.

Soo-Kyung Bae1, Su-Ryun Kim, Jong Gab Kim, Jee Yeon Kim, Tae Hyeon Koo, Hye-Ock Jang, Il Yun, Mi-Ae Yoo, Moon-Kyoung Bae.   

Abstract

Visfatin has been originally identified as a growth factor for early stage B cells and recently known as an adipokine. Here, we report that hypoxia induces the visfatin mRNA and protein levels in MCF7 breast cancer cells. We also demonstrate that induction of visfatin gene is regulated by hypoxia-inducible factor-1alpha (HIF-1alpha). Moreover, 5'-flanking promoter region of human visfatin gene contains two functional HIF responsive elements (HREs), activating the expression of visfatin. Mutation of these HREs in the visfatin promoter abrogates activation of a luciferase reporter gene driven by visfatin promoter under hypoxia. Taken together, our results demonstrate that visfatin is a new hypoxia-inducible gene of which expression is stimulated through the interaction of HIF-1 with HRE sites in its promoter region.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828081     DOI: 10.1016/j.febslet.2006.06.052

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  37 in total

1.  Nicotinamide Phosphoribosyltransferase in Human Diseases.

Authors:  Li Qin Zhang; Daniel P Heruth; Shui Qing Ye
Journal:  J Bioanal Biomed       Date:  2011-01-07

Review 2.  Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

Authors:  Stefan Kaluz; Milota Kaluzová; Shu-Yuan Liao; Michael Lerman; Eric J Stanbridge
Journal:  Biochim Biophys Acta       Date:  2009-01-22

3.  The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target.

Authors:  Lydia Brandl; Nina Kirstein; Jens Neumann; Andrea Sendelhofert; Michael Vieth; Thomas Kirchner; Antje Menssen
Journal:  Med Oncol       Date:  2018-11-20       Impact factor: 3.064

Review 4.  Nicotinamide phosphoribosyltransferase in malignancy: a review.

Authors:  Rodney E Shackelford; Kim Mayhall; Nicole M Maxwell; Emad Kandil; Domenico Coppola
Journal:  Genes Cancer       Date:  2013-11

5.  Increased Nicotinamide Phosphoribosyltransferase in Rhabdomyosarcomas and Leiomyosarcomas Compared to Skeletal and Smooth Muscle Tissue.

Authors:  Moiz Vora; Junaid Ansari; Rabie M Shanti; Diana Veillon; James Cotelingam; Domenico Coppola; Rodney E Shackelford
Journal:  Anticancer Res       Date:  2016-02       Impact factor: 2.480

Review 6.  Regulation of cell survival and death by pyridine nucleotides.

Authors:  Shin-Ichi Oka; Chiao-Po Hsu; Junichi Sadoshima
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

7.  Visfatin and endogenous secretory receptor for advanced glycation end-products in diabetic type 2 and non-diabetic patients undergoing intermittent hemodialysis.

Authors:  Leszek Niepolski; Alicja E Grzegorzewska; Monika Młot-Michalska
Journal:  Int Urol Nephrol       Date:  2009-01-31       Impact factor: 2.370

8.  Pre-B cell colony enhancing factor (PBEF/NAMPT/Visfatin) and vascular endothelial growth factor (VEGF) cooperate to increase the permeability of the human placental amnion.

Authors:  J M Astern; A C Collier; C E Kendal-Wright
Journal:  Placenta       Date:  2012-11-12       Impact factor: 3.481

9.  Visfatin levels in patients with severe pneumonia.

Authors:  Xie Juan; Yi-Ming Lu; Jin-Dong Shi; Xing-Qi Deng; Wei Long
Journal:  World J Emerg Med       Date:  2011

10.  The novel adipocytokine visfatin exerts direct cardioprotective effects.

Authors:  Shiang Y Lim; Sean M Davidson; Ajeev J Paramanathan; Christopher C T Smith; Derek M Yellon; Derek J Hausenloy
Journal:  J Cell Mol Med       Date:  2008-04-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.